Protocol Ledger

NCT04383119 · Phase II · RECRUITING

Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

Interventional Phase II clinical trial protocol NCT04383119 sponsored by Italian Sarcoma Group in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-10-29 Enrollment: 100 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04383119
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)100 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04383119
Protocol FieldVerified Registry Value
NCT IdentifierNCT04383119
Consolidated Lead SponsorItalian Sarcoma Group
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment100 participants (ESTIMATED)
Registered Start Date2021-10-29
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04383119
Hospital Research SiteLocationSite Profile
Istituto Clinico HumanitasRozzano, ItalyOpen Hospital Dossier ->
Istituto Europeo di OncologiaMilan, ItalyOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI